Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Head and Neck Neoplasms × Radiotherapy, Image-Guided × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Neuroblastoma 2 Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Craniopharyngioma 1 Choroid Plexus Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal, Breast 1

Interventions

Cisplatin 131 Radiotherapy 112 Cetuximab 81 Docetaxel 51 Fluorouracil 48 Paclitaxel 41 Radiotherapy, Intensity-Modulated 36 Carboplatin 34 pembrolizumab 29 Surveys and Questionnaires 18 Immunohistochemistry 16 Erlotinib Hydrochloride 16 Gefitinib 15 Nivolumab 14 Drug Therapy 14 Gene Expression Profiling 13 Gemcitabine 12 Pemetrexed 11 Chemotherapy, Adjuvant 11 durvalumab 10 Radiation 10 Polymerase Chain Reaction 10 Bevacizumab 10 Filgrastim 9 Amifostine 9 Surgical Procedures, Operative 8 Standard of Care 8 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Bortezomib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01853670 2015-03-30

IGRT

Beth Israel Medical Center

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡